Home
Biosensors for Medical Wearables
October 23 - October 24, 2023
Biosensors for Medical Wearables

Conference Overview

SAE Media Group and Medical Design Briefs Present
Biosensors for Medical Wearables
October 23-24, 2023 | Boston, MA, USA
-------------------------------------------------------------------------------------------

SAE Media Group’s 3rd Annual Biosensors for Medical Wearables Conference will be back for 2023 in Boston to bring together device developers, MedTech, component manufacturers and big pharma to share and discuss the exciting advances in the medical wearable technology landscape.


The wearable biosensors market has grown significantly in recent years leading to increasingly growing potential for medical applications and at home alternatives for patients. With growing applications and potential in remote patient monitoring, diagnosis, therapeutics and detection of disease, wearable sensors are attracting considerable interest due to their opportunities in better supporting patients, clinical outcomes and decisions. Furthermore, AI and connected technologies are furthering the potential opportunities of this industry. However, challenges including flexibility of wearable devices, the collection of clinical-grade data and advanced battery technologies still remain for the industry to overcome. This year’s conference looks to address these hot topics through case studies and industry insights.


This is a must attend event, giving you the chance to engage in the latest innovations that are accelerating the wearable biosensors industry. We hope to welcome you in October 2023!
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

FEATURED SPEAKERS

Alicia Chong Rodriguez

Alicia Chong Rodriguez

CEO, Bloomer Tech
Andreas Caduff

Andreas Caduff

Strategic Advisory Board, Digital Medicine Society
Branislav Vajdic

Branislav Vajdic

Founder and CEO, HeartBeam
Catherine Liao

Catherine Liao

Chief Strategy Officer, CardieX
Girish Gangadharan

Girish Gangadharan

VP, Strategy & Business Development, Spacelabs Healthcare
Grant Weller

Grant Weller

SVP Data Science, BioIntelliSense, Inc.
Janet Nikolovski

Janet Nikolovski

New Venture Lead, Johnson & Johnson
Jasmin Imsirovic

Jasmin Imsirovic

Associate Director, Takeda
Jason Case

Jason Case

Vice President, Research & Development, Patient Monitoring, Medtronic
Julius Klaas

Julius Klaas

CTO, Bottneuro AG
Kara Chappie

Kara Chappie

Director and Project Lead, Pfizer
Lorelie H. Villarete

Lorelie H. Villarete

Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)
Matteo Lai

Matteo Lai

CEO, Empatica
Mattia Alberto Lucchini

Mattia Alberto Lucchini

Head of Wearable Sensors Development, Datwyler Switzerland Inc.
Pierre-Alexandre Fournier

Pierre-Alexandre Fournier

Co-founder/CEO, Hexoskin
Sameer Dhamne

Sameer Dhamne

Director, Clinical Affairs, Neursantys, Inc.
Tero-Pekka Alastalo

Tero-Pekka Alastalo

Chief Medical Officer and President, US Operations, CardioSignal Inc
Tim Callahan

Tim Callahan

VP Scientific Affairs, Philips Pharma Solutions
Venk Varadan

Venk Varadan

CEO and Co-founder, Nanowear

Alicia Chong Rodriguez

CEO, Bloomer Tech
Alicia Chong Rodriguez

Alicia Chong Rodriguez is the CEO at Bloomer Tech. She graduated from the MIT Electrical Engineering & Computer Science program and MIT IDM, where her research focused on sex-specific, computationally-generated, cardiac biomarkers at the MIT Computational Cardiovascular Research Group. She received the MIT Legatum Fellowship and the MIT Graduate Women of Excellence Award. She has also been recognized as a 2018 Medtech Boston 40 under 40 Healthcare Innovator, and in the top 100 Female Founders across the U.S. by Inc Magazine. Prior to MIT she worked in the semiconductor industry at companies such as HP and Teradyne and co-founded MenTe en Acción (Mujeres en Tecnología) where she currently serves on the board as a technical advisor

Aceil Halaby is the COO at Bloomer Tech. She has a Bachelor of Fine Arts degree in industrial design from RISD and graduated from the MIT Integrated Design & Management master's program. Her thesis at the MIT Center for Collective Intelligence focused on highly productive product teams. She has won the Harvard Arab pitch competition, HITLAB's Women's Health Tech Challenge, and led Bloomer Tech to become part of the top 20 of MassChallenge finalists. She has also been recognized and interviewed by Forbes, MIT Tech Review, Cheddar and Bostinno.

Aceil Halaby and Alicia Chong Rodriguez are the founders of Bloomer Tech. The company is ushering in a new age of personalized healthcare, disease prevention, and management. Using patented augmented clothing and novel digital biomarkers, Bloomer Tech works with providers to reduce high rates of hospital readmissions, undertreatment, and underdiagnosis that can cause sudden deaths in often overlooked populations. Their vision is to increase access and inclusivity in cardiovascular research and treatment without changing a woman's lifestyle or leaving her health to chance.

The Bloomer Tech founders met at MIT and became the first venture funded startup focused on solutions for cardiovascular disease and stroke in women. Their patented technology platform leverages more than 20 years of evidence-based research showing sex and ethnicity-related differences in the cardiovascular system. This enables women, researchers, and care providers to learn from each individual's unique physiology and provide data-driven care remotely. The company was named to the Forbes list of 50 Women-Led Startups That Are Crushing Tech.

 

Andreas Caduff

Strategic Advisory Board, Digital Medicine Society
Andreas Caduff

Andreas Caduff has been a driving force in the development of non-invasive and contextualized physiological monitoring. He was serving as CTO of Solianis where he orchestrated the development of non-invasive glucose monitoring. He then founded Biovotion and served for 7 years as CEO, offering a state-of-the-art user-centric, analytics driven ecosystem, powered by medical wearable technology. Biovotion received several international awards and high calibre endorsements for its innovations, including an award from the XPrize Foundation. Biovotion was acquired by Biofourmis in 2019. Today he is working at the interface of secured medical technology, physiological monitoring and data science, towards a more holistic view of health.

Branislav Vajdic

Founder and CEO, HeartBeam
Branislav Vajdic

Branislav Vajdic, PhD, Founder and CEO of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Prior to HeartBeam, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded cardiovascular device company. Previously, he spent 23 years at Intel, where he was the designer of the first Flash memory and author of two key inventions that enabled Flash. He also led engineering groups responsible for Pentium 1 through 4 designs. He is the author of numerous patents and publications. Dr. Vajdic holds a PhD in Electrical Engineering from the University of Minnesota.

Catherine Liao

Chief Strategy Officer, CardieX
Catherine Liao

A passionate technologist and entrepreneur known for her intuition, hustle and know how, Catherine Liao has an uncanny ability to recognize the white space where technology can be used to solve unmet needs. At age 19, Catherine got her start in tech working as a systems engineer for one of the first Internet conferencing services in the 90s. That eventually led her to the World Health Organization, where she successfully scaled WHO’s web infrastructure during the peak of the SARS epidemic, when demand for content exploded 20x overnight, topping over 14 million hits a day. As the Chief Strategy of CardieX, Catherine now leads the go-to-market strategy for an innovative global medical devices company specializing in heart health.

Prior to CardieX, Catherine served as the co-founder and CEO of Blumio, a venture-backed startup that developed a wearable sensor for blood pressure monitoring. The company was acquired by CardieX in 2022. Before embarking on her entrepreneurial journey, Catherine worked with some of the world’s largest enterprises, leveraging technology to drive business outcomes for over a decade. At Cisco, she helped commercialize technologies that enhanced the efficiency of business-critical applications, including the timely transmission of medical images, a breakthrough that allowed physicians to make medical decisions without delays. Leading a solutions marketing team at Riverbed, she spearheaded the go-to-market strategy of the company’s application performance platform.

An active leader in the startup community with an MBA from Imperial College London and MSc in Health Economics from London School of Economics, Catherine provides guidance and mentorship to other entrepreneurs as an Executive Mentor for Santa Cruz Accelerates and a Program Lead for the Startup Leadership Program. In her downtime, you’ll likely find Catherine at her favorite wine bar where she is serves as an investor—and chief glass washer.

Girish Gangadharan

VP, Strategy & Business Development, Spacelabs Healthcare
Girish Gangadharan

Girish Gangadharan leads Commercial Strategy & Business Development at Spacelabs. In his current role Girish is responsible for strategy formulation & execution, M&A, new product commercialization and strategic partnerships. Previously he spent around 10 years at Analogic Corporation leading teams in corporate M&A, business development, product management and strategic planning. Girish holds an MBA from Boston University.

 

Grant Weller

SVP Data Science, BioIntelliSense, Inc.
Grant Weller

Grant Weller is Vice President, Data Science at BioIntelliSense, Inc., a Denver-based continuous health monitoring and clinical intelligence company. Grant is responsible for the development and implementation of cloud-based data-as-a-service (DaaS) algorithms supporting patient monitoring both in-hospital and at home. BioIntelliSense's FDA-cleared technology stack includes the BioButton device, BioCloud DaaS platform, and AlertWatch clinician-facing monitoring services. Grant has a decade of experience in data science leadership roles in the wearables and digital health industry, previously as Vice President of Research with UnitedHealth Group's Optum Labs division, and as a Senior Scientist at Savvysherpa, Inc., a Minneapolis-based healthcare research & development firm. He has published in both methodological and clinical journals and holds several patents in the health monitoring space. He is a graduate of Concordia College in Moorhead, MN with a B.A. in Mathematics and Economics. He received an M.S. and Ph.D. in Statistics from Colorado State University, and was previously Visiting Assistant Professor in the Statistics and Data Science department of Carnegie Mellon University.

Janet Nikolovski

New Venture Lead, Johnson & Johnson
Janet Nikolovski

Janeta is an innovation leader with over 20 years of experience in Research & Product Development. She is Director of Innovation in the World Without Disease Accelerator at Janssen and is co-leading a large digital and device-based cardiovascular clinical trial. Her career has spanned the Pharmaceutical, Consumer, and Device sectors, having worked on strategy and product development, clinical study design and execution, behavioral science related to digital health and solution development, and external partnerships. Janet holds a Ph.D. in Biomedical Engineering and B.S. in Chemical Engineering from the University of Michigan.

 

Jasmin Imsirovic

Associate Director, Takeda
Jasmin Imsirovic

Jasmin Imsirovic is an Associate Director in Digital Health Sciences at Takeda where he advises clinical teams on the strategy and implementation of digital devices in clinical trials. His focus is on leading validation studies of devices, assessing new technologies and supporting teams in device selection and digital biomarker development. Prior to joining Takeda, Jasmin was a Principal Scientist at Respiratory Motion Inc where he oversaw algorithm and software development for an FDA-cleared respiratory monitor, as well as its implementation in clinical studies. He attended Boston University where he earned BS, MS and PhD degrees in Biomedical Engineering.

 

Jason Case

Vice President, Research & Development, Patient Monitoring, Medtronic
Jason Case

Jason Case currently serves as Vice President of Research & Development within Medtronic’s Patient Monitoring operating unit.

With more than 2 decades in the medical device industry, Jason has had the opportunity to research, develop, market and sell innovative diagnostic and therapeutic systems and devices in interventional cardiology, interventional oncology and patient monitoring.

Jason has successfully led R&D organizations driving best in class R&D vitality and effectiveness in support of Medtronic growth businesses in Early Technologies, Gastrointestinal & Hepatology and most recently in Health Informatics & Monitoring.

Jason holds Master’s and Bachelor‘s degrees in Biomedical Engineering from the University of Iowa.

 

Julius Klaas

CTO, Bottneuro AG
Julius Klaas

Bottneuro aspires to become the premier provider of custom-made devices for diagnosing and treating neurological diseases, employing digital biomarkers, brain imaging, and neuromodulation technologies. To realize this vision, we utilize AI and customized 3D manufacturing technologies to create entirely tailored solutions for both patients and researchers. In 2021, Julius Klaas joined the Bottneuro team to spearhead technical development and currently serves as the Chief Technology Officer of the company. He has a strong interest in anti-aging technologies.

Kara Chappie

Director and Project Lead, Pfizer
Kara Chappie

Kara Chappie is a Director and Research Project Lead within the Digital Sciences and Translational Imaging (DSTI) group in Early Clinical Development (ECD) at Pfizer, located in Cambridge, MA. She leads a team of scientists researching the use of acoustic (speech) signals to detect/monitor disease in remote clinical trial applications. Prior to her role at Pfizer, she modeled sound propagation for underwater acoustic applications. She received her Ph.D. in Electrical Engineering/Signal Processing from Yale University.

Lorelie H. Villarete

Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)
Lorelie H. Villarete

Lorelie Villarete, Ph.D. is manager of Clinical Affairs for Lingo, Abbott's consumer biowearables division. Since joining Abbott in 2021, Dr. Villarete has worked on Abbott's biowearables clinical development for both medical and consumer use. Prior to Abbott, Dr. Villarete has held various scientific, strategic, and operations roles from discovery to the clinic in the pharmaceutical, diagnostics, and medical device industries. Dr. Villarete is passionate in developing transformative products that help people live a healthier and fuller life. Dr. Villarete holds a bachelor's degree from Loyola Marymount University and a doctorate degree from University of California, Los Angeles.

Matteo Lai

CEO, Empatica
Matteo Lai

Matteo Lai is the CEO and co-founder of Empatica, an MIT spinoff and pioneer in developing medical wearables and digital biomarkers for remote health monitoring driven by AI.

Through his versatile background and passion for design and healthcare, he has led Empatica in creating medical-grade technology that is driven by human-friendly design. Empatica’s products include the FDA-cleared Empatica Health Monitoring Platform and EmbracePlus wearable, co-developed with NASA and the HHS and used by some of the world’s top research institutions, and Embrace2, the only FDA-cleared wrist-worn wearable that detects seizures in people with epilepsy.

Matteo studied Engineering, trained as an Architect, holds a Double MSc degree in Architecture, and a Masters in Innovation Management. He is a DiMe contributor, and was named by Sifted as one of the top pioneers of the European startup world.
 

Mattia Alberto Lucchini

Head of Wearable Sensors Development, Datwyler Switzerland Inc.
Mattia Alberto Lucchini

Mattia Lucchini is an Italian material scientist with a PhD in Physical Chemistry. He moved to Switzerland 8 years ago and after a 2 years postdoc at ETH Zurich, he joined Datwyler as a material developer. For the past two years, he has been responsible for the technology development of wearable sensors.
Mattia is passionate about BCI and wearable technology, and his research focuses on developing innovative materials and products in this field. He is particularly interested in developing wearable sensors that can be used to monitor and track human health and performance.

 

Pierre-Alexandre Fournier

Co-founder/CEO, Hexoskin
Pierre-Alexandre Fournier

Pierre-Alexandre Fournier is an engineer, scientist, designer and entrepreneur, co-founder and CEO of Hexoskin, a Montreal-based company focused on clinical-grade wearable sensors and AI software for health and clinical research.
Hexoskin launched in 2013 the first iPhone compatible smart clothing for health monitoring, which won several international awards. In 2018 Hexoskin launched a remote health monitoring system for astronauts doing research aboard the International Space Station. Hexoskin products designed by Pierre-Alexandre and his team are now used by hundreds of research organisations around the world to collect medical data and push the boundaries of medical knowledge in real-life settings. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.

 

Sameer Dhamne

Director, Clinical Affairs, Neursantys, Inc.
Sameer Dhamne

Sameer Dhamne serves as Director of Clinical Affairs at Neursantys, a company pioneering the development of wearable diagnostic and therapeutic medical devices. With over 15 years of inter-disciplinary experience in translational neuromodulation and neurophysiology research, Sameer’s work has focused on advancing novel clinical interventions for neurological disorders. Prior to Neursantys, Sameer has held scientific, managerial, and operations roles bridging the gap between research and development in academia, digital health, and medical device industry. He has authored over 100 publications encompassing peer-reviewed papers, book chapters and conference abstracts. Sameer holds Master’s and bachelor’s degrees in Biomedical Engineering.

Tero-Pekka Alastalo

Chief Medical Officer and President, US Operations, CardioSignal Inc
Tero-Pekka Alastalo

Tero-Pekka Alastalo MD, PhD is the President and Chief Medical Officer of CardioSignal and based in San Francisco Bay Area. He has 20+ years of experience in cardiovascular and genomic medicine as a physician, researcher, and entrepreneur.

Tim Callahan

VP Scientific Affairs, Philips Pharma Solutions
Tim Callahan

Dr. Timothy Callahan is the VP of Scientific Affairs for Philips Pharma Solutions (formerly BioTel Research). He brings over 35 years of clinical research expertise to the position including research with the NIH and more than 30 years in the diagnostic testing industry. Dr. Callahan co-authored 3 patents in QT interval analysis and dynamical systems modeling of ECG data. He has authored many abstracts and publications as well as serving as the moderator for FDA QT-IRT – ECG Core Lab meetings. He is a frequent speaker at Pharmaceutical Industry functions.


 

Venk Varadan

CEO and Co-founder, Nanowear
Venk Varadan

Venk is the CEO & Co-founder of Nanowear, a commercial-stage, healthcare-at-home digital monitoring and machine learning diagnostic platform. Nanowear’s SimpleSense platform is the first-and-only monitoring platform powered by proprietary cloth-based nanotechnology, which continuously, simultaneously and time synchronously monitors and assesses the heart, lungs and central vascular and hemodynamic system by replacing first-line diagnostics tools.
Before Nanowear, Venk spent ~7 years at UBS Investment Bank, Citadel Investment Group and Wells Fargo Securities in New York. Venk spent ~ 3 years in product marketing and sales with both Lilly and Sanofi Pharmaceuticals in New York.
Venk received his MBA from Columbia University and his BSE from Duke University.
 

sponsors

Conference agenda

clock

8:00

Registration & Coffee

clock

9:00

Co- Chair's Opening Remarks

Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

clock

9:10

Biowearables: Evolution and vision for harnessing direct real-time internal biomarker data from our bodies

Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

  • Overview of the evolution of bio/wearables technology
  • Insights on continuous biomarker monitoring of interstitial fluid (ISF) as it relates to health and disease
  • Personalized data driven technologies and what they mean to the future of consumer-led healthcare
     
  • clock

    9:50

    Non-Adhesive, Flexible Wearable Sensors for Pulmonary Medical Applications

    Pierre-Alexandre Fournier, Co-founder/CEO, Hexoskin

  • Utilising smart clothing for pulmonary medical applications and reviewing the challenges to be overcome for long-term wearables
  • Exploring digital biomarkers for pulmonary conditions including COPD, asthma and chronic cough
  • Delving into the collection and processing of data from the smart garment monitoring platform
  • Leveraging collaborations with universities and research hospitals to further research and advance the potential of long-term sensor technologies
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Panel Discussion: Evolving Digital Medical Opportunities and Emerging Technologies

  • Insight into new therapeutic applications of biosensors and emerging uses
  • How can industry work together to accelerate and further opportunities in medical biosensors and connected devices
  • Advancing how data is used to enhance patient care and diagnostics
  • Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Venk Varadan, CEO and Co-founder, Nanowear

    Alicia Chong Rodriguez, CEO, Bloomer Tech

    Grant Weller, SVP Data Science, BioIntelliSense, Inc.

    clock

    11:40

    Transforming Health Monitoring with the use of Medical-Grade Technologies

    Jason Case, Vice President, Research & Development, Patient Monitoring, Medtronic

  • Overview of challenges and opportunities for monitoring patients as they shift from higher acuity settings in the hospital to lower acuity settings, and eventually, back home
  • Overview of the Medtronic Patient Monitoring business, including the technology portfolio, and why medical-grade technologies are so important to address challenges in the patient monitoring space
  • Discuss how current medical-grade solutions solve the issue of the “monitoring cliff” when patients shift to different settings in the hospital and when they are discharged home (multiparameter wearable, connected data capture and visualization)
  • Address future technological applications to better capture vitals and important patient biomarkers anytime, anywhere
  • clock

    12:20

    Networking Lunch

    clock

    13:20

    Medical Grade Monitoring in Hospital to Home

    Grant Weller, SVP Data Science, BioIntelliSense, Inc.

  • Current state of device wearables capabilities in hospital and at home
  • How medical grade monitoring impacts/assists healthcare staff
  • Future of medical grade wearables from in hospital to home
  • clock

    14:00

    Heartline Study: Evolving Digital Clinical Evidence Generation

    Janet Nikolovski, New Venture Lead, Johnson & Johnson

  • Background on the Heartline study and update on current status
  • Utilizing direct to patient enrolment and engagement in remote studies with digital tools
  • Practices for enhancing patient engagement and allowing the patient to work with healthcare providers to understand how to reduce risks
  • Assessing key learnings from the heartline study so far and looking at steps moving forwards

     

  • clock

    14:40

    Afternoon Tea

    clock

    15:10

    Transforming Remote Care Models in Heart Diseases with Motion-Sensor Technology

    Catherine Liao, Chief Strategy Officer, CardieX

  • Cardiovascular diseases are a growing burden, and delayed diagnostics leaves many at-risk patients vulnerable to adverse health outcomes. In this presentation, we introduce how a novel motion sensor technology, gyrocardiography, can be utilized to improve care paths in cardiovascular care
  • Examples include care models in population health, remote patient monitoring and point-of-care diagnostics
  • Opportunities in clinical trials and patient identification will also be discussed
  • Presenting a case example in heart failure, and what the standard of care looks like in the future
  • clock

    15:50

    Wearables for the Diagnosis and Monitoring of Cardiovascular Diseases

    Branislav Vajdic, Founder and CEO, HeartBeam

  • Case study on a sensor that is designed for heart attack detection
  • Design strategies for production of a patient-friendly device to monitor pressure changes in the heart
  • Ensuring accuracy and a high threshold for statistically significant data
  • Exploring how the biosensor has improved cardiac patient monitoring so far and potential future applications for similar devices
  • clock

    16:30

    Co-Chair’s Closing Remarks and Close of Day One

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Co- Chair's Opening Remarks

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

    clock

    9:10

    Effective and Efficient Use of Wearables for Decentralised Clinical Trials

    Tim Callahan, VP Scientific Affairs, Philips Pharma Solutions

  • Maximising the developments in wearable technologies and bolstering capabilities for decentralised clinical trials
  • Best practises and strategies for a successful decentralised clinical trial design
  • What steps still need to be made before decentralized clinical trials are adopted into healthcare strategy?
  • Case study on ePatch: delivering continuous, ECG data for 24 hours and up to 14 days
  • Utilising cloud-based software powered by AI to streamline ECG analysis
  • clock

    9:50

    Partnering with Pharma to Implement Biosensors in Clinical Trials

    Jasmin Imsirovic, Associate Director, Takeda

  • What are the unique needs of pharma clinical trials and how can they be met by partnering with wearables companies?
  • Selecting appropriate measures from biosensors and demonstrating scientific acumen through validation, regulatory clearance, or publication track record
  • Reducing the operational complexity of biosensors to improve clinical site and patient experience
  • Navigating the onboarding process and demonstrating clinical trial readiness as a vendor
     
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Advantages and challenges with clinical adoption of wearables

    Girish Gangadharan, VP, Strategy & Business Development, Spacelabs Healthcare

  • Usability and ubiquity of wireless sensing
  • Clinical evidence for implications on clinical workflow
  • Costs, and other operational considerations when considering wearables
  • clock

    11:40

    SoftPulse™ - best-in-class dry electrodes for wearables and their application in 3D-printed, fully personalized caps for brain recording and stimulation

  • SoftPulse™ rubber-based dry electrodes as best-in-class components for wearable devices
  • Properties and advantages of SoftPulse™ electrodes for bio-potential acquisition
  • 3D-printed wearable for perfect fit, stable electrical contact, designed for home use
  • Electrode positions fully customized for multi-focal stimulation and source EEG (tACS, tDCS, EEG)
     
  • Mattia Alberto Lucchini, Head of Wearable Sensors Development, Datwyler Switzerland Inc.

    Julius Klaas, CTO, Bottneuro AG

    clock

    12:20

    Speech Data Collection on Mobile Devices: Observations from a BOYD, Decentralized Clinical Trial

    Kara Chappie, Director and Project Lead, Pfizer

  • Considerations when collecting speech for acoustic analyses in a remote clinical trial
  • Preparing remote data for analyses: Did you collect the data you were expecting?
  • Are traditional speech acoustic features similar on varied devices?
  • clock

    13:00

    Networking Lunch

    clock

    14:00

    Healthcare-At-Home Device & Digital Solutions: Addressing and Managing All Stakeholders & When

    Venk Varadan, CEO and Co-founder, Nanowear

  • Discussing how remote diagnostics and clinical decision support utilizing AI and machine learning is now the prominent focus for all stakeholders in healthcare
  • Shedding light on how digital-only solutions are limited in the clinical and diagnostic services for dynamic data, particularly those utilizing AI and machine learning
  • Rethinking how device plus digital artificial intelligence and machine learning must be developed in parallel with all stakeholders in mind: patients, providers, regulators and payers
  • clock

    14:40

    From biosensor to endpoint: Building a full-stack digital biomarker platform to advance medical research

    Matteo Lai, CEO, Empatica

  • Incorporation of multiple sensors into a wearable device to derive PPG, electrodermal activity, temperature, accelerometer and gyroscope data
  • Ensuring ease-of use for patients and clinical trial participants through user-centric design
  • Developing and validating a digital biomarker portfolio
  • Applications: From scaling decentralized clinical trials to seizure detection for people living with epilepsy
  • clock

    15:20

    Afternoon Tea

    clock

    15:50

    Analysing and Interpreting Data Collected from Biometric Monitoring Technologies in Clinical Trials

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

  • What is needed from the device perspective for better data collection?
  • Ensuring data collected is medical grade and best practises for generating evidence for clinical validity
  • Exploring the regulatory pathways through which clinical validity evidence may be reviewed
  • Addressing the common pitfalls of dealing with data at scale in clinical research
  • Discussing the potential ways industry can use sensor generated data to make better, faster decisions
  • clock

    16:30

    Electroceuticals vs Pharmaceuticals

    Sameer Dhamne, Director, Clinical Affairs, Neursantys, Inc.

  • How are electroceuticals providing an alternative to pharmaceuticals? Cost considerations and more
  • Maximising the potential of neurostimulation techniques to counteract neurophysiological conditions and disease
  • Reviewing the challenges in the design and development of devices for neurostimulation delivery
  • Case studies on electroceutical applications: Balance decline, Parkinson’s disease, stroke, multiple sclerosis, depression, pain and more
  • clock

    17:10

    Co- Chair's Closing Remarks and Close of Day Two


    CEO
    Bloomer Tech
    Strategic Advisory Board
    Digital Medicine Society
    Founder and CEO
    HeartBeam
    Chief Strategy Officer
    CardieX
    VP, Strategy & Business Development
    Spacelabs Healthcare
    SVP Data Science
    BioIntelliSense, Inc.
    New Venture Lead
    Johnson & Johnson
    Associate Director
    Takeda
    Vice President, Research & Development, Patient Monitoring
    Medtronic
    CTO
    Bottneuro AG
    Director and Project Lead
    Pfizer
    Manager, Clinical Affairs
    Lingo Sensing Technology Unlimited Company (An Abbott Company)
    CEO
    Empatica
    Head of Wearable Sensors Development
    Datwyler Switzerland Inc.
    Co-founder/CEO
    Hexoskin
    Director, Clinical Affairs
    Neursantys, Inc.
    Chief Medical Officer and President, US Operations
    CardioSignal Inc
    VP Scientific Affairs
    Philips Pharma Solutions
    CEO and Co-founder
    Nanowear

    Sponsors

    Exhibitors

    VENUE

    Courtyard by Marriott Boston Downtown

    Boston, USA

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Preliminary Attendee List

    Download

    Speaker Interview: Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Download

    Speaker Interview: Mattia Lucchini, Head of Wearable Sensors Development at Datwyler

    Download

    Speaker Interview: Tim Callahan, VP Scientific Affairs, Philips Pharma Solutions

    Download

    Speaker Interview: Janet Nikolovski, New Venture Lead, Johnson & Johnson

    Download

    Welcome from the Chairs

    Download

    Past Presentation: Eric Richardson, MedRhythms

    Download

    Past Attendee List

    Download

    Brochure

    Download

    Past Presentation: Orel Swenson, Biofourmis

    Download

    Sponsors


    Datwyler

    Sponsors
    https://datwyler.com/company/innovation/softpulse

    Datwyler is a leading manufacturer of system-critical elastomer components for advanced applications in healthcare, mobility, and other industries. Based on our core competencies solution design, material expertise, and operational excellence, we deliver customer value from idea to industrialization.

    SoftPulse™ soft dry electrodes are Datwyler solution for long-term and gel-free ExG monitoring. Our electrodes made from conductive elastomer offer high wear comfort thanks to the softness of the material. Dry signal acquisition without use of gel shortens preparation time and allows ambulatory ExG applications. Robust design and easy cleanability enable repeated use. The combination of superior materials and optimized production processes leads to best-in-class signal quality among soft dry electrodes with excellent stability against ageing and abrasion.

    SoftPulse™ are available in three standard designs. Thanks to Datwyler core competences, electrodes are produced using fully scalable manufacturing processes. Customization according to customer needs are as well possible for small and serial volumes.


    Exhibitors


    East West

    Exhibitors
    https://www.ewmfg.com/

    East West is a global manufacturing services company focused on the realization of products, from design through distribution. As specialists in onshore, nearshore, and offshore manufacturing, we offer a seamless path to scale and an exceptional speed-to-market strategy while driving down costs and adhering to the highest quality standards. We are one integrated family, working together to support our customers throughout the entire product lifecycle. Our vision is to make the world a better place – cleaner, safer, healthier and smarter. East West offers its customers solutions in automation and robotics, industrial technology, IoT and smart devices, biosensors, and medical wearables.



    Lohmann

    Exhibitors
    https://www.lohmann-tapes.us/us/site__264/?

    Lohmann is a privately held, German based company. We are a pressure sensitive adhesive manufacturer with converting capabilities. We have US based manufacturing sites in Hebron Kentucky and Orange Virginia. We manufacture backing materials and cover tapes for lateral flow along with component parts for wearable, ostomy, drape tapes and other medical related applications.


    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Courtyard by Marriott Boston Downtown


    USA

    Courtyard by Marriott Boston Downtown

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description

    Video



    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out